(RTTNews) - Today's Top Gainers list includes CODX, which is advancing the development of its Ebola PCR Assay; NRXP, which has a couple of ...
Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...
Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic's C1 Platform Capabilities for Fast, Scalable Biologic ProductionJUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic ...
Impfungen bei MS – sicher oder riskant? Ein Überblick von klassischen Schutzimpfungen bis zu innovativen Therapieversuchen.
Innerhalb der letzten Jahre sind Australiens Schifffahrtskapazitäten drastisch eingebrochen. Wie das Portal „Maritime Executive“ berichtet, ist die Zahl der unter australischer Flagge fahrenden Handel ...
Empress Royalty Corp. is pleased to announce its financial and operating results for the three months ended March 31, 2026, highlighting continued portfolio performance, disciplined execution, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results